Published in Cost Eff Resour Alloc on June 21, 2004
Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr (2007) 2.58
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS. Patient Educ Couns (2009) 1.64
The economic impact of ME/CFS: individual and societal costs. Dyn Med (2008) 1.56
The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed (2006) 1.41
Using multiple sources of knowledge to reach clinical understanding of chronic fatigue syndrome. Ann Fam Med (2008) 1.34
A train-the-trainer education and promotion program: chronic fatigue syndrome--a diagnostic and management challenge. BMC Med Educ (2008) 1.21
Web usage data as a means of evaluating public health messaging and outreach. J Med Internet Res (2009) 1.19
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One (2010) 1.17
The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res (2011) 1.15
Barriers to healthcare utilization in fatiguing illness: a population-based study in Georgia. BMC Health Serv Res (2009) 1.06
Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol (2010) 1.05
The hidden cost of chronic fatigue to patients and their families. BMC Health Serv Res (2010) 1.05
Personality features and personality disorders in chronic fatigue syndrome: a population-based study. Psychother Psychosom (2010) 1.02
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct (2008) 1.00
The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Eff Resour Alloc (2011) 0.97
Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry (2009) 0.95
Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue. PLoS One (2014) 0.88
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res (2016) 0.86
Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med (2012) 0.86
Kindling and Oxidative Stress as Contributors to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Behav Neurosci Res (2009) 0.86
Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. Health Promot Chronic Dis Prev Can (2015) 0.85
Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). PLoS One (2015) 0.83
Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden. BMC Health Serv Res (2013) 0.83
An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med (2009) 0.83
Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr J (2009) 0.83
A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One (2012) 0.82
Continuing medical education challenges in chronic fatigue syndrome. BMC Med Educ (2009) 0.82
DNA methylation modifications associated with chronic fatigue syndrome. PLoS One (2014) 0.81
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open (2016) 0.80
Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico. Am J Trop Med Hyg (2016) 0.79
GB virus-C--a virus without a disease: we cannot give it chronic fatigue syndrome. BMC Infect Dis (2005) 0.79
An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder. J Affect Disord (2016) 0.78
Tracking post-infectious fatigue in clinic using routine Lab tests. BMC Pediatr (2016) 0.78
Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms. World J Methodol (2015) 0.77
Association among measures of mobility-related disability and self-perceived fatigue among older people: a population-based study. Braz J Phys Ther (2015) 0.77
Illness progression in chronic fatigue syndrome: a shifting immune baseline. BMC Immunol (2016) 0.76
Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Symptom Severity: Stress Management Skills are Related to Lower Illness Burden. Fatigue (2013) 0.76
Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients compared to healthy controls: a case-control study. J Transl Med (2015) 0.75
Telephone-administered versus live group cognitive behavioral stress management for adults with CFS. J Psychosom Res (2016) 0.75
How common is chronic fatigue syndrome; how long is a piece of string? Popul Health Metr (2007) 0.75
Evaluation of the anti-fatigue effects of a traditional herbal drug, Gongjin-dan, under insufficient sleep conditions: study protocol for a randomised controlled trial. Trials (2016) 0.75
Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Fatigue (2016) 0.75
Patterns of control beliefs in chronic fatigue syndrome: results of a population-based survey. BMC Psychol (2017) 0.75
Factors Associated with Fatigue among Men Aged 45 and Older: A Cross-Sectional Study. Int J Environ Res Public Health (2015) 0.75
Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin Epidemiol (2016) 0.75
Long-term parental unemployment in childhood and subsequent chronic fatigue syndrome. ISRN Family Med (2013) 0.75
Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial. PLoS One (2017) 0.75
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24
Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev (1987) 10.58
A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04
The economic value of human life. Am J Public Health Nations Health (1967) 5.22
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
The economic costs of illness: a replication and update. Health Care Financ Rev (1985) 4.23
Estimating the cost of illness. Am J Public Health Nations Health (1967) 2.45
The economic impact of chronic fatigue syndrome. Med J Aust (1992) 2.13
Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care (1996) 2.08
The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med (2003) 1.90
Natural history of severe chronic fatigue syndrome. Arch Phys Med Rehabil (1999) 1.30
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
The labor productivity effects of chronic backache in the United States. Med Care (1998) 1.15
Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome. Ann Epidemiol (2000) 1.03
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
The United States rheumatology workforce: supply and demand, 2005-2025. Arthritis Rheum (2007) 3.23
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol (2008) 1.93
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun (2008) 1.78
Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom Med (2009) 1.69
The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics (2006) 1.63
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med (2005) 1.47
Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population. Health Qual Life Outcomes (2003) 1.46
Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis (2007) 1.44
Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry (2009) 1.32
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med (2004) 1.22
A train-the-trainer education and promotion program: chronic fatigue syndrome--a diagnostic and management challenge. BMC Med Educ (2008) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med (2003) 1.20
Web usage data as a means of evaluating public health messaging and outreach. J Med Internet Res (2009) 1.19
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model (2007) 1.18
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci (2007) 1.15
Chronic fatigue syndrome and other fatiguing illnesses in adolescents: a population-based study. J Adolesc Health (2004) 1.15
Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab (2007) 1.14
Association of childhood trauma with cognitive function in healthy adults: a pilot study. BMC Neurol (2010) 1.13
Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr (2009) 1.12
Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res (2004) 1.12
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Complementary and alternative medical therapy utilization by people with chronic fatiguing illnesses in the United States. BMC Complement Altern Med (2007) 1.10
Prevalence of symptoms and symptom-based conditions among Gulf War veterans: current status of research findings. Epidemiol Rev (2002) 1.09
Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics (2008) 1.09
Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology (2008) 1.08
Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 1.06
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
Seroprevalence of human papillomavirus type 16 in children. J Infect Dis (2005) 1.06
Barriers to healthcare utilization in fatiguing illness: a population-based study in Georgia. BMC Health Serv Res (2009) 1.06
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Impaired immune function in Gulf War Illness. BMC Med Genomics (2009) 1.03
U.S. healthcare providers' knowledge, attitudes, beliefs, and perceptions concerning Chronic Fatigue Syndrome. BMC Fam Pract (2010) 1.02
Personality features and personality disorders in chronic fatigue syndrome: a population-based study. Psychother Psychosom (2010) 1.02
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct (2008) 1.00
Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metr (2004) 0.98
Sleep assessment in a population-based study of chronic fatigue syndrome. BMC Neurol (2004) 0.97
Impact of RNA extraction from limited samples on microarray results. Biotechniques (2003) 0.95
Postinfective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis (2007) 0.94
Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis (2006) 0.94
Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. J Psychosom Res (2006) 0.94
Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med (Berl) (2004) 0.93
Hypersomnolence and sleep-related complaints in metropolitan, urban, and rural Georgia. Am J Epidemiol (2008) 0.93
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol (2005) 0.92
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. BMC Genomics (2005) 0.92
A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci (2007) 0.92
Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. Metabolism (2010) 0.92
Assessment of normal variability in peripheral blood gene expression. Dis Markers (2002) 0.91
Exploration of neuroendocrine and immune gene expression in peripheral blood mononuclear cells. Brain Res Mol Brain Res (2004) 0.91
Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas. Health Qual Life Outcomes (2003) 0.91
Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med (2008) 0.91
Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia. Health Qual Life Outcomes (2009) 0.90
Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput Biol (2009) 0.90
Impact of acute psychosocial stress on peripheral blood gene expression pathways in healthy men. Biol Psychol (2009) 0.89
Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology (2006) 0.89
Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics (2006) 0.89
Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens. BMC Infect Dis (2003) 0.88
Laboratory methods to improve SELDI peak detection and quantitation. Proteome Sci (2007) 0.87
Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurol (2007) 0.87
Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study. Psychosom Med (2008) 0.86
Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia. Psychosom Med (2009) 0.86
Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med (2012) 0.86
Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project. Mayo Clin Proc (2012) 0.86
A pilot study of immune network remodeling under challenge in Gulf War Illness. Brain Behav Immun (2010) 0.85
Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2006) 0.85
Antibody response to Culex tarsalis salivary gland antigens among sentinel chickens in California. Am J Trop Med Hyg (2005) 0.84
Detection of chicken antibodies to mosquito salivary gland antigens by enzyme immunoassay. J Am Mosq Control Assoc (2005) 0.84
An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med (2009) 0.83
Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis (2005) 0.83
Continuing medical education challenges in chronic fatigue syndrome. BMC Med Educ (2009) 0.82
Validation of ECG-derived sleep architecture and ventilation in sleep apnea and chronic fatigue syndrome. Sleep Breath (2009) 0.82
Exploring the diagnostic potential of immune biomarker coexpression in Gulf War Illness. Methods Mol Biol (2012) 0.82
Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. Cancer Epidemiol Biomarkers Prev (2007) 0.82
Cumulative life stress in chronic fatigue syndrome. Psychiatry Res (2011) 0.82
Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study. Gynecol Oncol (2005) 0.81
Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects. BMC Microbiol (2002) 0.81
Gynecological history in chronic fatigue syndrome: a population-based case-control study. J Womens Health (Larchmt) (2010) 0.81
Electroencephalographic correlates of Chronic Fatigue Syndrome. Behav Brain Funct (2009) 0.81
Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue. Popul Health Metr (2009) 0.80
Gene expression profiling of dysplastic differentiation in cervical epithelial cells harboring human papillomavirus 16. Genomics (2005) 0.80
Global amplification of sense RNA: a novel method to replicate and archive mRNA for gene expression analysis. Genomics (2003) 0.80
The comparison of different pre- and post-analysis filters for determination of exon-level alternative splicing events using Affymetrix arrays. J Biomol Tech (2010) 0.79
GB virus-C--a virus without a disease: we cannot give it chronic fatigue syndrome. BMC Infect Dis (2005) 0.79
Absence of Mycoplasma species DNA in chronic fatigue syndrome. J Med Microbiol (2003) 0.79